Avanir Pharmaceuticals, Inc.
is a biopharmaceutical company focused on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders.

Press Releases

Avanir Pharmaceuticals to Present Data on ONZETRA™ Xsail™ at American Headache Society (AHS) 2016 Annual Scientific Meeting
Jun 9, 2016
NUEDEXTA® Effective for Pseudobulbar Affect (PBA) in Patients with Alzheimer’s Disease and other Dementias, Stroke and Traumatic...
Jun 8, 2016
AVANIR Pharmaceuticals Announces U.S. Launch and Availability of ONZETRA™ Xsail™ for the Acute Treatment of Migraine in Adults
May 16, 2016